Alkermes Recognizes Their Employees' Unwavering Commitment To Patients

As we approach the second anniversary of the COVID-19 pandemic, our Head of Human Resources, Steve Schiavo, took time to reflect on the appreciation we have for all our employees – especially those in key business areas, including research, development, manufacturing and distribution, and more, whose critical work has required them to continue working on-site. Your hard work and dedication to the patients for whom our medicines are designed to help inspires us every day. Read more here.

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.